Amgen drug approved for osteoporosis in men
THOUSAND OAKS, Calif. — The Food and Drug Administration has approved a new usage for an Amgen drug, the drug maker said.
The biotech manufacturer announced the FDA approval of Prolia (denosumab) to increase bone mass in men with osteoporosis who are at high risk for fracture. The drug already was approved for osteoporosis in postmenopausal women.
According to the National Institutes of Health, the number of men with osteoporosis is expected to increase as the number of men older than 70 years grows, and about one-quarter of men older than 50 years will have an osteoporosis-related fracture in their lifetime, according to the National Osteoporosis Foundation, which estimated the condition affects 2 million men, with 12 million more at risk.
Walgreens donates 3,000 flu shots to high school students in Tennessee
KNOXVILLE, Tenn. — Walgreens has donated 3,000 doses of flu vaccine to Knox County high school students, valued at $100,000, according to a report in the Knoxville News Sentinel published Thursday.
"This is just an extraordinary effort to really focus on keeping our kids healthy in school," Jim McIntyre, Knox County Schools superintendent, told the Sentinel. "We know that as we get into the winter months, making sure that our kids are healthy is an important prerequisite to having them in school and making sure that they are learning every day."
To redeem the complimentary flu shot, students participating in the program need to present a vaccination administration form to any local Walgreens pharmacy.
According to the report, Knox County boasts one of the highest school-aged children vaccination rates in the country.
For the full report, click here.
FDA approves Mylan motion sickness drug
PITTSBURGH — The Food and Drug Administration has approved a generic drug for motion sickness made by Mylan.
The drug maker announced Friday that the FDA had approved meclizine hydrochloride tablets in the 12.5-mg, 25-mg and 50-mg strengths. Mylan said it would launch the drug immediately.
The drug is a generic version of Pfizer’s Antivert, which is used to treat nausea, vomiting and dizziness associated with motion sickness. Antivert had sales of about $53.5 million during the 12-month period ended in June, according to IMS Health.